← All medicines
BLENREP 70 mg powder for concentrate for solution for infusion
Licence EU/1/25/1948/001 · Unknown
- Licence holder
- GlaxoSmithKline Trading Services Limited (all products →)
- Active substance
- Belantamab Mafodotin
- Dosage form
- Powder for concentrate for solution for infusion
- Route of administration
- Intravenous use
- ATC code
- L01FX15
- First authorised
- 23/07/2025
- Prescription status
- Product subject to prescription which may not be renewed (A)
- Supply
- Supply through pharmacies only
- Legal basis
- Full application (Article 8(3) of Directive No 2001/83/EC)
Data: Health Products Regulatory Authority (HPRA) open dataset, licensed CC BY 4.0, published 04 Jul 2026. This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.